More Business Wire
View Older Stories View Newer Stories-
Walgreens Boots Alliance to Participate in 42nd Annual J.P. Morgan Healthcare Conference
-
InterSystems Positioned as a Challenger in the 2023 Gartner® Magic Quadrant™ for Cloud Database Management Systems
-
Achievers Is a Category Leader and Visionary in Employee Recognition in 2023
-
Textron to Release Fourth Quarter Results on January 24, 2024
-
Kansas City Proton Institute Begins Cancer Treatments with Advanced MEVION S250i Proton Therapy System
-
Global Shipments of Smart TVs Poised to Make a Slow Recovery, According to IDC
-
Amylyx Pharmaceuticals Announces First Participant Dosed in the Global Phase 3 ORION Study of AMX0035 in Progressive Supranuclear Palsy (PSP)
-
26 Tissue Donors Who Gave the Gift of Life and Two Tissue Recipients Whose Lives Were Transformed by the Power of Donation will Participate in the 2024 OneLegacy Donate Life Float on New Year’s Day
-
Citi Appointed as Depositary Bank for ZKH Group Limited ADR Program
-
Shore Capital Partners Announces Partnership with Bundled Management
-
GoodRx Appoints Kelly J. Kennedy to Board of Directors
-
Advent Technologies Announces $2 Million Registered Direct Offering of Common Stock
-
Safe & Green Holdings Corp. Announces That David Cross, VP of Sales and Business Development, Has Been Selected to Serve on the Modular Building Institute’s Government Affairs Committee
-
AEye Announces Reverse Stock Split to Ensure Nasdaq Minimum Bid Price Compliance
-
Madryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioTools
-
CEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate Developments
-
Patritumab Deruxtecan Granted Priority Review in the U.S. for Certain Patients with Previously Treated Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
-
OliX Pharmaceuticals Receives HREC Approval to Initiate Phase 1 Clinical Trial of NASH and Obesity Drug
-
Getty Realty Corp. Announces 2023 Getty Gives Activity
-
Medical Home Network, NeueHealth Help FQHCs Achieve $10.1M+ Savings
-
Sarepta Therapeutics Submits Efficacy Supplement to Expand the ELEVIDYS Label to include Duchenne Muscular Dystrophy Patients without Restriction to Age or Ambulatory Status
-
GAN Announces Changes to its Board of Directors
-
Playmaker Capital Mails Management Information Circular for Special Meeting of Shareholders
-
HB Capital and Social Capital Partners Establish Strategic Partnership to Advance Employee Ownership Initiatives
-
Five Leading Semiconductor Industry Players Incorporate New Company, Quintauris, to Drive RISC-V Ecosystem Forward
-
Cummins reaches agreement in principle to settle regulatory proceedings regarding its emissions certification and compliance process for pick-up truck applications
-
Universal Electronics Inc. Announces Cooperation Agreement with Immersion Corporation
-
Northisle Announces Issuance of Share-based Compensation
-
Pebblebrook Hotel Trust Completes $30.0 Million Sale of Marina City Retail Space and Parking Facilities in Downtown Chicago
-
Diversified Healthcare Trust Closes $941 Million Zero Coupon Senior Secured Notes with a Maturity Date in January 2026, and a One-Year Extension Option
-
Holiday to Remember: a Home Ownership Dream Becomes Reality With a Hand From Nissan
-
POSaBIT Applies to List Common Shares on the TSXV
-
QuidelOrtho to Present at 42nd Annual J.P. Morgan Healthcare Conference
-
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
-
Bristol Myers Squibb to Present at J.P. Morgan’s 42nd Annual Healthcare Conference
-
AECOM selected as delivery partner for Eglinton Crosstown West Extension in Toronto
-
Kolibri Global Energy Inc. Provides 2023 Guidance Update and Operations Update
-
Chemours, DuPont, and Corteva Provide Update and Affirm Support for PFAS Settlement with U.S. Water Systems
-
Tilly’s, Inc. Announces Participation in ICR Conference 2024
-
2024 to Bring “Reputational Security” into Focus – Crisis Management Centre
-
FDA Approves Label Update for BRUKINSA® (zanubrutinib) in Chronic Lymphocytic Leukemia (CLL)
-
Spotify Technology S.A. to Announce Financial Results for Fourth Quarter 2023
-
Best Buy Canada Launches Extra Hot Deals for Boxing Day - The Biggest Shopping Day of the Year
-
CTP Acquires Site in Germany for Major New High-Tech Business Park
-
Healthcare Trust Announces Preferred Stock Dividends
-
Rio Tinto Board changes
-
Tikehau Capital: Disclosure of Shares Repurchases from 15 December to 21 December 2023
-
Accenture Expands Digital Transformation Capabilities for Italy’s Public Sector with Acquisition of Customer Management IT and SirfinPA
-
Cellusion Receives U.S. FDA Orphan Drug Designation for CLS001
-
KuCoin Labs Announces Its Strategic Partnership with Zoopia, a Platform Dedicated to Bitcoin Ecosystem Staking, to Further Support the Development of BTC Ecosystem

